Acrocyanosis after neoadjuvant ipilimumab plus nivolumab: A case report

I. L. M. Reijers; M. Hilhorst; M. Tan; P. L. Klarenbeek; A. E. Hak; C. U. Blank

Acrocyanosis after neoadjuvant ipilimumab plus nivolumab: A case report

I. L. M. Reijers
, M. Hilhorst
, M. Tan
, P. L. Klarenbeek
, A. E. Hak
, C. U. Blank^*

^*Corresponding author for this work

Affiliatie UvA

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	1031-1032
Number of pages	2
Journal	Clinical and experimental rheumatology
Volume	38
Issue number	5
Publication status	Published - 1 Sept 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{11c14f631f9242339158fc0ba3a43fb9,

title = "Acrocyanosis after neoadjuvant ipilimumab plus nivolumab: A case report",

author = "Reijers, \{I. L. M.\} and M. Hilhorst and M. Tan and Klarenbeek, \{P. L.\} and Hak, \{A. E.\} and Blank, \{C. U.\}",

year = "2020",

month = sep,

day = "1",

language = "English",

volume = "38",

pages = "1031--1032",

journal = "Clinical and experimental rheumatology",

issn = "0392-856X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

number = "5",

}

TY - JOUR

T1 - Acrocyanosis after neoadjuvant ipilimumab plus nivolumab: A case report

AU - Reijers, I. L. M.

AU - Hilhorst, M.

AU - Tan, M.

AU - Klarenbeek, P. L.

AU - Hak, A. E.

AU - Blank, C. U.

PY - 2020/9/1

Y1 - 2020/9/1

UR - https://www.scopus.com/pages/publications/85092575188

M3 - Comment/Letter to the editor

C2 - 32301417

SN - 0392-856X

VL - 38

SP - 1031

EP - 1032

JO - Clinical and experimental rheumatology

JF - Clinical and experimental rheumatology

IS - 5

ER -

Acrocyanosis after neoadjuvant ipilimumab plus nivolumab: A case report

UN SDGs

Other files and links

Cite this